Projects per year
Personal profile
Education/Academic qualification
MD, University of North Texas Health Science Center, 12376, School of Public Health, Fort Worth, Texas, United States.
Projects
-
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NRG-GY020)
Farach, A. M., Alaniz, A., Butler, E. B., Darcourt, J., Haque, W. M., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M., Suri, A. & Zaid, T.
6/22/20 → …
Project: Clinical Trial
-
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy (VOCAL)
Kamat, A. A., Alaniz, A., Suri, A. & Zaid, T.
3/12/20 → …
Project: Clinical Trial
-
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer (NRG-GY018)
Zaid, T., Alaniz, A., Darcourt, J., Singh, M. & Suri, A.
11/22/19 → …
Project: Clinical Trial
-
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (ENGOT-0V44 The FIRST)
Suri, A., Alaniz, A., Darcourt, J., Singh, M. & Zaid, T.
7/30/19 → …
Project: Clinical Trial